期刊文献+

LC-MS/MS法测定人血浆中舒芬太尼的血药浓度 被引量:14

Determination of sufentanil in human plasma by LC-MS/MS
原文传递
导出
摘要 目的建立液质联用(LC—MS/MS)法测定血浆中舒芬太尼血药浓度。方法以芬太尼为内标,血浆样品经乙腈沉淀蛋白后,以Ultimate XB C18(100mm×2.1mm,3.0μm)柱为色谱柱,流动相为水-甲醇(15:85,V/V),各含10mmol·L^-1乙酸铵,流速为0.2mL·min^-1,柱温加℃;质谱条件为电喷雾电离源(ESI),检测方式为正离子电离、多离子反应监测(MIIM),用于定量分析的离子为舒芬太尼m/z387.2→238.1,芬太尼m/z337.2→188.2。结果舒芬太尼线性范围为0.05~2μg·L^-1(r=0.9964),线性关系良好。舒芬太尼的提取回收率为83.68%。88.06%。批内和批间精密度RSD均〈10%。结论本研究建立的测定舒芬太尼血药浓度的方法简单、快速、准确、灵敏,可用于临床上血药浓度监测和药动学研究。 AIM To develop a LC-MS/MS assay to determine sufentanil in human plasma. METHODS Fentanyl was used as an interal standard. Plasma samples were precipitated by acetonitril. The separation was carried out on an Ultimate XB C18( 100 mm × 2.1 mm, 3.0 μm) column at 40℃. The mobile phase consisted of water-methanol solu- tion ( 15 : 85, V/V) with 10 mmol·L^-1 ammonium acetate at a flow-rate of 0.2 mL·min^-1. Electrospray ionization(ESI) source was applied and operated in the positive ion mode. Quantitaion was performed using multiple reaction monitoring (MRM) of the m/z 387.2→238.1 for sufentanil, and m/z 337.2→188.2 for fentanyl. RESULTS The liner calibration curves were obtained in the range of 0.05 - 2μg·L^-1 for sufentanil. The extraction recovery for sufentanil was ranged from 83.68 % - 88.06%. The relative standard deviation of the intra-assay and inter-assay precision of variation was less than 10%. CONCLUSION It is an accurate, sensitive and rapid method that can be applied to the evaluation of sufentanil target, and suitable for clinical pharmacokinetic study of sufentanil.
出处 《中国临床药学杂志》 CAS 2010年第2期93-96,共4页 Chinese Journal of Clinical Pharmacy
基金 广东省科技厅成果推广项目(编号2005C13G0101)
关键词 液质联用 舒芬太尼 血药浓度 LC-MS/MS sufentanil plasma drug concentration
  • 相关文献

参考文献6

  • 1Movig KL, Langen MC, Egberts AC. Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high-performance liquid chromatography [J]. J Pham Biomed Anal, 1999, 21(4): 845.
  • 2Schmidt R, Bremerich DH, Geisslinger G. High sensitive determination of sufentanil in human plasma of parturients and neonates following patient-controlled epidural analgesia ( PCEA ) [ J ]. J Chromatogr Analyt Technol Biomed Life Sci, 2006,836(1- 2): 98.
  • 3Pallesehi L, Lucentini L, Ferretti E, et al. Quantitative determination of sufentanil in human plasma by liquid chromatography-tandem mass spectrometry[J]. J Pham Biomed Anal,2003,32(2) : 329.
  • 4Martens-Lobenhoffer J. Very sensitive and specific determination of sufentanil in human serum applying liquid chromatography-two stage mass spectrrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2002,769(2): 227.
  • 5肖彬,张兴安,施冲.舒芬太尼临床药动学研究及应用[J].中国现代应用药学,2008,25(4):298-301. 被引量:37
  • 6刘维,段京莉,张现化,赵艳,张利萍.液相色谱-质谱联用测定全身麻醉患者血浆中舒芬太尼浓度[J].中国临床药理学杂志,2008,24(3):245-248. 被引量:31

二级参考文献27

  • 1张加强,邢玉英,孟凡民.靶控输注系统的性能评价[J].国外医学(麻醉学与复苏分册),2005,26(5):301-304. 被引量:10
  • 2Movig KLL, Langen MCJ, Egberts ACG. Analysis of low concentration sufentanil citrate/bupivacaine hydrochloride admixtures, using solid phase extraction followed by high - performance liquid chromatography [ J ]. J Pharm Biomed Analy, 1999 ;21 : 845 - 850.
  • 3Martens - Lobenhoffer J. Very sensitive and specific determination of sufentanil in human serum applying liquid chromatography - two stage mass [J]. J Chromatogr B, 2002 ;769 : 227 -233.
  • 4Schmidt R, Bremerich DH, Geisslinger G. High sensitive determination fo sufentanil in human plasma of parturients and neonates following patient- controlled epidural analgesia (PCEA) [J]. J Chromatogr B, 2006 ;836:98 - 107.
  • 5Palleschi L, Lucentini L, Ferretti E, et al. Quantitative determination of sufentanil in human plasma by liquid chromatography - tandem mass spectrometry [ J ]. J Pharm Biomed Analy, 2003 ;32:329 -336.
  • 6Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer - controlled infusion pumps [ J ] J Pharmacokinet Biopharm, 1992 ;20:63 - 94.
  • 7Maitre PO, Ausems ME, Vozeh S, et al. Evaluating the accuracy of using population pharmacokinetic data to predict plasma concentrations of alfentanil [ J ]. Anesthesiology, 1988 ;68:59 - 67.
  • 8WOESTENBORGHS R J, TIMMERMAN P M, CORNELISSEN M L, et al. Assay methods for sufentanll in plasma. Radloimmunoassay versus gas chromatography-mass spectrometry [ J ]. Anesthesiology, 1994,80 (3) :666-670.
  • 9ROSSI S S, KYCK J B, YAKSH T L. Simultaneous extraction of sufentanil and midazolam from human plasma [ J]. Clin Chim, 1996,244( 1 ) :103 -110.
  • 10BORENSTEIN M, SHUPAK R, BARNETTE R, et al. Cardiovascular effects of different infusion rates of sufentanil in patients under going eoronary surgery[ J]. Eur J Clin Pharmaeol, 1997,51 (5) :359-366.

共引文献65

同被引文献91

引证文献14

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部